Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib versus Bendamustine plus Rituximab (BR) in Patients with Treatment-Naive (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

#2021
#BLOOD

PMU Authors
Richard Greil, Alan Cohen

All Authors
CS Tam, K. Giannopoulos, W. Jurczak, M. Simkovic, M. Shadman, A. Osterborg, L. Laurenti, P. Walker, S. Opat, H. Chan, H. Ciepluch, Richard Greil, M. Tani, M. Trneny, DM Brander, IW Flinn, S. Grosicki, E. Verner, JR Brown, BS Kahl, P. Ghia, T. Tian, C. Marimpietri, JC Paik, Alan Cohen, J. Huang, T. Robak, P. Hillmen

Journal association
BLOOD

Abstract